Pharmaceutical Lipids Market Trends, Share, Opportunities and...

Pharmaceutical Lipids Market Trends, Share, Opportunities and Forecast By 2032

Posted 2024-02-12 07:51:34

According to a new report published by K D Market Insights, titled, “Pharmaceutical Lipids Market Insights, Trends, Opportunity & Forecast, 2023–2032,” the global pharmaceutical lipids market size is anticipated to witness moderate growth during the forecast period i.e., 2023-2032. The increasing demand for lipid-based drug delivery systems and advancements in pharmaceutical research and development. Pharmaceutical lipids play a crucial role in enhancing the bioavailability and therapeutic efficacy of drugs which are the major factors augmenting the growth of the global pharmaceutical lipids market.

The expanding pharmaceutical industry and advancements in healthcare technologies play a crucial role in market growth. The increasing demand for innovative drug delivery systems and the development of lipid-based formulations are further expected to create ample growth opportunities for the global pharmaceutical lipids market during the forecast period i.e., 2023-2032. Moreover, the rising prevalence of neurological, cardiovascular, and cancer conditions has propelled market expansion. Growing focus on personalized medicine and precision therapies, is expected to contribute towards the market growth during the period.

The North America region accounted for the largest share in the global pharmaceutical lipids market in 2022. The region is further projected to continue dominating in the market and also register the highest CAGR in the market during the forecast period. This can be attributed to the presence of major pharmaceutical companies, research institutes, and advancements in drug delivery technologies.

According to product type, the triglycerides segment accounted for the largest market share in the pharmaceutical lipids market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.

The global pharmaceutical lipids market is segmented into product type, source, form, application, route of administration and region. Based on product type, the market is bifurcated into triglycerides, phospholipids, sphingolipids, cholesterol, fatty acids, others. Based on source, it is classified into synthetic, semi-synthetic, natural. Based on form, it is classified into liquid, semi-solid, solid. Based on application, it is classified into conventional lipid-based drug delivery systems, self-emulsifying drug delivery systems, self-micro emulsifying drug delivery systems, liposomes, solid lipid nanoparticles, nanostructured lipid carriers, others. Based on route of administration, it is classified into oral, tablet, solution, parenteral, intravenous, intramuscular (vaccines), topical.

The global pharmaceutical lipids market is analyzed across North America (U.S. & Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East & Africa).

Key Insights of Pharmaceutical Lipids Market

On the basis of product type, the triglycerides segment accounted for the largest market share in the pharmaceutical lipids market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
On the basis of region, North America accounted for the largest share in the global pharmaceutical lipids market in 2022. The region is further projected to continue dominating in the market during the forecast period.
On the basis of region, Asia-Pacific is estimated to account for the second largest share in the market during the forecast period.

Some of the major pharmaceutical lipids companies profiled in the report include ABITEC Corporation (ABF Ingredients), BASF SE, Croda International Plc, CordenPharma, NOF (Nippon Oil & Fats) Corporation, Cayman Chemical Company, Lipoid GmbH, Nippon Fine Chemical Co. Ltd., Dishman Group, Gattefossé, IOI Oleo GmbH, Stepan Company, and Evonik Industries AG.